Developing a Fluorescence-Based High-Throughput Screening Method for Natural Product Fractions to Identify Inhibitors of AR-V7 for Castration-Resistant Prostate Cancer.

Tyagi N, Rathi M, Ensel S, Thornburg CC, Grkovic T, O'Keefe BR, Sacchettini JC, Damodaran C

Open source

DOI
10.3390/pharmaceutics18091158
Published
2026 Sep 15
Container
Pharmaceutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18091158,
  title = {Developing a Fluorescence-Based High-Throughput Screening Method for Natural Product Fractions to Identify Inhibitors of AR-V7 for Castration-Resistant Prostate Cancer.},
  author = {Tyagi N and Rathi M and Ensel S and Thornburg CC and Grkovic T and O'Keefe BR and Sacchettini JC and Damodaran C},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18091158},
  url = {https://doi.org/10.3390/pharmaceutics18091158}
}

RIS

TY  - JOUR
TI  - Developing a Fluorescence-Based High-Throughput Screening Method for Natural Product Fractions to Identify Inhibitors of AR-V7 for Castration-Resistant Prostate Cancer.
AU  - Tyagi N
AU  - Rathi M
AU  - Ensel S
AU  - Thornburg CC
AU  - Grkovic T
AU  - O'Keefe BR
AU  - Sacchettini JC
AU  - Damodaran C
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18091158
UR  - https://doi.org/10.3390/pharmaceutics18091158
ER  - 

APA

N, T., M, R., S, E., CC, T., T, G., BR, O., JC, S., & C, D. (2026). Developing a Fluorescence-Based High-Throughput Screening Method for Natural Product Fractions to Identify Inhibitors of AR-V7 for Castration-Resistant Prostate Cancer.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18091158

Source records